PEP-Therapy

0 followers


PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.

Industries

Headquarters

Employees

Links

Org chart

Antoine Prestat
Co-founder & CEO

Antoine Prestat

Collapse
Jennifer Sengenès
Head of Strategy & Development
Laura Dadon
Head of Regulatory Affairs & Development
Michele Marzola
Director and Lead Investor